Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

美信罗 - NMPA Drug Approval Details

Approvals/NMPA/Methoxy Polyethylene Glycol-Epoetin beta

Approved

生物制品

Methoxy Polyethylene Glycol-Epoetin beta

Roche Pharma (Schweiz) AG🇨🇳 National Medical Products Administration

Approval Date: Jan 10, 2023
Approval ID: c3e7bb7ce47a07fc
Company: Roche Pharma (Schweiz) AG
Type: 生物制品

Approval Details

Approval Id: c3e7bb7ce47a07fc
Approval Number: 国药准字SJ20180004
Generic Name: 甲氧聚二醇重组人促红素注射液
Generic Name En: Methoxy Polyethylene Glycol-Epoetin beta
Trade Name: 美信罗
Drug Type: 生物制品
Dosage Form: 注射剂
Strength: 75μg/0.3ml/支：每支预充式注射器内含75μg甲氧聚二醇重组人促红素，装量为0.3ml
Reg Date: 2023-01-10
Expired Date: 2028-01-09
Company Name: Roche Pharma (Schweiz) AG
Company Detail Path: /organization/roche-pharma-schweiz-ag

Approved

Quick Info

Agency

NMPA

Country

🇨🇳

Approval Date

Jan 10, 2023

Approval ID

c3e7bb7ce47a07fc

Type

生物制品

Back to NMPA Approvals